关于我们
Preclinical biotechnology company leveraging proprietary structure-based technology to develop small molecule disaggregators and inhibitors targeting previously undruggable misfolded proteins in neurodegenerative diseases. Our pipeline consists of tau, TDP-43 and alpha-synuclein programs.
- 网站
-
https://adrxpharma.com
ADRx, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Thousand Oaks,California
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Research
地点
-
主要
515 Marin St
Suite 314
US,California,Thousand Oaks,91360